FILTER

Refine your search with the following facets to narrow down your results.

5 Current news of DuoCort

ViroPharma Completes Acquisition of DuoCort Pharma AB

17-Nov-2011 - ViroPharma Incorporated announced that it completed its acquisition of DuoCort Pharma AB. The acquisition of Duocort Pharma AB further expands ViroPharma's orphan disease commercial product pipeline. ViroPharma has paid an upfront closing cost of 220 million Swedish kroner (SEK) or $33.6 ...

acquisitions ViroPharma

DuoCort Pharma and Recipharm start collaboration for the treatment of Addison’s disease

28-Oct-2010 - DuoCort Pharma announces it has concluded an agreement with Recipharm under which Recipharm is set to scale-up the manufacturing of DuoCort’s tablets to commercial scale as DuoCort Pharma prepares for market entry with its orphan drug for the treatment of Addison’s disease. The scale-up agreement ...

adrenal insufficiency cardiovascular diseases density +1

DuoCort: New chronotherapy for adrenal insufficiency

30-Jun-2009 - DuoCort published data from its Phase I study for the rare and life threatening disease adrenal insufficiency. The release profile of DuoCort’s new form of treatment with once-a-day hydrocortisone dosing closely resembles the physiological secretion pattern. The data is published in the European ...

absorption adrenal insufficiency endocrinology

Successful phase II/III trial of new therapy for adrenal insufficiency

16-Jun-2009 - DuoCort gained promising data from its Phase II/III study for the rare and life threatening disease adrenal insufficiency. DuoCort’s new form of physiological treatment with once-a-day hydrocortisone dosing show improved cardiovascular and metabolic measures compared to standard hydrocortisone ...

adrenal insufficiency diabetes dosing +3

DuoCort completes enrolment for pivotal phase II-III adrenal insufficiency trial

13-Dec-2007 - DuoCort Pharma AB announced that targeted enrolment is complete in the pivotal phase II-III clinical trial evaluating 5 mg and 20 mg DuoCort dual-release hydrocortisone tablets for the treatment of adrenal insufficiency - the inability of the body to produce sufficient amounts of the essential ...

adrenal insufficiency bioavailability clinical trials +3